Beth P. Hecht
Chief Legal Officer and Corporate Secretary
Beth P. Hecht serves as the Chief Legal Officer and Corporate Secretary of Xeris Pharmaceuticals. She has over 25 years of experience as a corporate executive in the life science industry, most recently serving as Managing Director and Chief Legal and Administrative Officer for Auven Therapeutics, a global biotechnology and pharmaceutical private equity firm. Beth is currently a member of the Board of Directors of Iterum Therapeutics (Nasdaq: ITRM) and a member of both the Audit and Compensation Committees there. She was previously on the Board of Directors of Neos Therapeutics where she chaired the Nominating and Governance Committee.
Ms. Hecht is a graduate of Amherst College and Harvard Law School; she began her career as an attorney specializing in intellectual property and corporate transactions at Willkie Farr & Gallagher (NY) and later Kirkland & Ellis (NY). She has established and led legal, compliance, licensing, human resource, and security departments at companies including Durata Therapeutics, Sun Products, MedPointe Inc. (formerly Carter-Wallace Inc.), Warner Chilcott PLC, ChiRex Ltd., and Alpharma Inc.
Ms. Hecht is a graduate of Amherst College and Harvard Law School; she began her career as an attorney specializing in intellectual property and corporate transactions at Willkie Farr & Gallagher (NY) and later Kirkland & Ellis (NY). She has established and led legal, compliance, licensing, human resource, and security departments at companies including Durata Therapeutics, Sun Products, MedPointe Inc. (formerly Carter-Wallace Inc.), Warner Chilcott PLC, ChiRex Ltd., and Alpharma Inc.